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The Ephrin VAB-2/EFN-1 Functions in Neuronal
Signaling to Regulate Epidermal Morphogenesis
in C. elegans
leading cells to the ventral midline, and second, enclo-
sure of the posterior epidermis. A catenin/cadherin sys-
tem is required for normal movement of the anterior
epidermal cells, and likely functions within epidermal
cells to modulate cytoskeletal behavior (Costa et al.,
Ian D. Chin-Sang, Sean E. George, Mei Ding,
Sarah L. Moseley, Andrew S. Lynch,
and Andrew D. Chisholm*
Department of Biology
Sinsheimer Laboratories
University of California 1998).
We reported previously that the vab-1 (vab, variableSanta Cruz, California 95064
abnormal) gene functions in two phases of embryonic
morphogenesis: first, in the movement of neuroblasts
during closure of the ventral gastrulation cleft, and sec-
Summary ond, in epidermal ventral enclosure (George et al., 1998).
vab-1 encodes a C. elegans Eph receptor tyrosine ki-
The Eph receptor VAB-1 is required in neurons for nase, and is required nonautonomously in the nervous
epidermal morphogenesis during C. elegans em- system for normal epidermal development. Vertebrate
bryogenesis. Two models were proposed for the non- Eph receptors bind ligands known as ephrins (reviewed
autonomous role of VAB-1: neuronal VAB-1 might sig- in Flanagan and Vanderhaeghen, 1998). Ephrin/Eph re-
nal directly to epidermis, or VAB-1 signaling between ceptor signaling functions in many diverse processes
neurons might be required for epidermal development. (reviewed by Holder and Klein, 1999), including axon
We show that the ephrin VAB-2 (also known as EFN-1) guidance, somitogenesis, angiogenesis, neural crest
is a ligand for VAB-1 and can function in neurons to cell migration (Krull et al., 1997; Smith et al., 1997), and
regulate epidermal morphogenesis. In the absence of cell sorting during segmentation of rhombomeres (Xu
VAB-1 signaling, ephrin-expressing neurons are disor- et al., 1999). Vertebrate ephrins are either membrane
ganized. vab-2/efn-1 mutations synergize with vab-1 anchored by a glycosylphosphatidylinositol (GPI) an-
kinase alleles, suggesting that VAB-2/EFN-1 may partly chor (ephrin-As) or are transmembrane proteins (ephrin-
function in a kinase-independent VAB-1 pathway. Our Bs). Ephrin-Bs become phosphorylated on cytoplasmic
data indicate that ephrin signaling between neurons tyrosyls in response to receptor binding (Holland et al.,
is required nonautonomously for epidermal morpho- 1996; BruÈ ckner et al., 1997). EphB receptors thus func-
genesis in C. elegans. tion as bidirectional signaling molecules, with both
ªforwardº (kinase-dependent) signaling and ªreverseº
(kinase-independent) signaling via ephrin-B ligandsIntroduction
(Henkemeyer et al., 1996). Mutations that affect the ki-
nase domain of VAB-1 do not cause complete loss ofEpithelial cells display many types of morphogenetic
function, suggesting that VAB-1 might also have bothbehavior. A common type of epithelial morphogenesis
kinase-dependent and kinase-independent functions.is the spreading of an epithelial sheet over a substrate,
VAB-1 is mainly expressed in the nervous system andas in embryonic epiboly and wound closure (Bard, 1992).
loss of vab-1 function in neurons causes defects in epi-Epibolic movements may be driven by cell proliferation
dermal morphogenesis (George et al., 1998). We pro-or changes in cell shape, and have been described in
posed two models for this nonautonomous role of VAB-1.the embryos of many animal phyla. Dorsal closure of
In a ªsteric hindranceº model, VAB-1 signaling oper-the Drosophila epidermis is a well-studied example of
ates between neurons; lack of VAB-1 leads to disorga-epiboly. Many genes have been identified that function
nization of neurons, and epidermal cells are unablein dorsal closure, including the myosin zipper, compo-
to migrate normally over this substrate. In a ªreversenents of a MAP kinase/JNK signal transduction pathway
signalº model, VAB-1 signals from neurons to ligand-that functions in the leading edge cells, and components
expressing epidermal cells. To distinguish between theseof a TGFb pathway required to transduce signals from
models, we sought ligands for VAB-1. Here we show thatthe leading edge cells (reviewed in Noselli and Agnes,
the vab-2 gene is also required for neural and epidermal1999). Epiboly in the zebrafish requires the Jak1 kinase
morphogenesis and encodes a C. elegans GPI-anchored(Conway et al., 1997); several genes required for zebra-
ephrin, also known as EFN-1. VAB-2/EFN-1 is expressedfish epiboly have also been isolated in genetic screens
in neurons adjacent to VAB-1-expressing neurons, and(Kane et al., 1996; Solnica-Krezel et al., 1996).
not in epidermal cells. Analysis of vab-1; vab-2 doubleThe epidermis of the nematode C. elegans is an epi-
mutants suggests that, unexpectedly, VAB-2/EFN-1thelium that undergoes epiboly during embryogenesis,
may partly function in a kinase-independent VAB-1where it encloses the embryo ventrally (Sulston et al.,
pathway.1983). Ventral enclosure is the result of epidermal cell
shape changes (Williams-Masson et al., 1997) and in-
Resultsvolves two steps: first, the extension of four anterior
vab-2 Encodes a C. elegans Ephrin
We anticipated that mutations in ligands for VAB-1 might* To whom correspondence should be addressed (e-mail: chisholm@
biology.ucsc.edu). cause similar phenotypes to those of vab-1 mutants.
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Table 1. Strength of vab-2/efn-1 Mutations and Molecular Lesions
Embryonic Larval Adult, Adult, Wild-Type Mutant
Allele Arrest Arrest Vab Non-Vab Sequence Sequence Effect
Strong
ut78 8.4% 25.7% 38.7% 27.1% CAA TAA Q8ochre
e2640 10.2% 24.2% 34.0% 31.6% CAA TAA Q27ochre
ju1 11.9% 19.2% 45.0% 24.0% TGG TGA W30opal
n1443 12.3% 18.4% 37.0% 32.2% TGG TGA W202opal
e96 11.1% 23.3% 29.9% 35.6% CGA TGA R265opal
vab-1(dx31) 50.8% 33.2% 14.0% 2.0%
Intermediate
e141 8.9% 14.5% 55.8% 20.7% TGT TAT C90Y
e1208 8.8% 15.0% 51.0% 25.2% CCG CTG P108L
Weak
ju90 3.0% 2.6% 7.3% 87.0% ATG ATA M1I
sy167 7.6% 8.1% 39.3% 45.0% T T T|gtga T T T|atga exon 3
splice
donor
We classified vab-2/efn-1 mutations as strong (.30% embryonic 1 larval lethality), intermediate (20%±30% lethality) or weak (,20% lethality);
the vab-1 null allele dx31 (George et al., 1998) is included for comparison. Wild-type and mutant vab-2/efn-1 genomic DNA sequences are
shown, with the predicted effects on VAB-2/EFN-1 protein.
Mutations in the vab-2 gene cause defects in epidermal To test whether VAB-2/EFN-1 binds VAB-1, we tested
whether the extracellular domain of VAB-1 expressedmorphogenesis like those of vab-1 (Brenner, 1974). Ex-
amination of sequence data for the vab-2 genomic re- as a soluble fusion protein with alkaline phosphatase
(VAB-1-AP) could bind 293T cells expressing VAB-2/gion revealed a predicted ephrin gene; all vab-2 alleles
cause sequence alterations in this gene (Table 1), show- EFN-1. VAB-1-AP binding to cells expressing VAB-2/
EFN-1 was detectable by staining for AP (Figures 2Fing that this gene is vab-2. Four C. elegans ephrin (efn)
genes have been identified (Wang et al., 1999), among and 2G) and was abolished by pretreatment with PI-
PLC or with anti-VAB-2/EFN-1 antibodies (Figure 2G,which vab-2 corresponds to efn-1; in this paper we will
refer to this gene as vab-2/efn-1. and data not shown). VAB-1-AP colocalized with VAB-2
when bound to VAB-2-expressing cells (Figures 2H±2J).We confirmed the structure of the vab-2/efn-1 gene
(see Experimental Procedures). VAB-2/EFN-1 is most We measured the affinity of VAB-1-AP for VAB-2/EFN-1
in equilibrium binding experiments (Figure 2K). Specificsimilar to vertebrate ephrins (Pandey et al., 1995). Verte-
brate ephrins are GPI-anchored (ephrin-A) or transmem- binding curves of VAB-1-AP to cells expressing VAB-2/
EFN-1 showed saturation, with a calculated KD of 5 nM,brane (ephrin-B) proteins. VAB-2/EFN-1 contains a pre-
dicted GPI attachment signal at its C terminus and thus comparable to vertebrate Eph receptor-ephrin KDs of
0.1±25 nM (Flanagan and Vanderhaeghen, 1998); nega-is structurally similar to vertebrate ephrin-As. The con-
served domain of VAB-2/EFN-1 is significantly more tive controls showed lower binding and no saturation
(Figure 2K). These data show that VAB-2/EFN-1 can bindsimilar to those of ephrin-Bs than to those of ephrin-
As (Figure 1C). VAB-2 thus shares features with both VAB-1 with high affinity.
Finally, we asked whether the missense mutationssubfamilies of vertebrate ephrins. Five strong vab-2/
efn-1 alleles result in nonsense mutations (Table 1; Fig- caused by the vab-2 alleles e141 and e1208 affected
the affinity of VAB-2/EFN-1 for VAB-1. The C90Y andure 1B) and are probably null mutations. Two intermedi-
ate alleles, e141 and e1208, encode missense alter- P108L mutant VAB-2/EFN-1 proteins were expressed at
equivalent levels to wild-type VAB-2/EFN-1 (Figure 2C),ations (C90Y and P108L) in the receptor binding domain.
and did not show specific binding to VAB-1 (Figure 2L).
Thus, mutations that reduced the affinity of VAB-2/VAB-2/EFN-1 is GPI-Anchored and Binds VAB-1
with High Affinity EFN-1 for VAB-1 also reduced vab-2/efn-1 function.
Vertebrate EphA receptors bind ephrin-A ligands, and
EphB receptors bind ephrin-B ligands (Gale et al., 1996).
vab-2/efn-1 Mutants Display DefectsVAB-1 is equally similar to the EphA and EphB receptor
in Morphogenesis Similar to Thosesubfamilies (George et al., 1998). Because VAB-1 and
of vab-1 MutantsVAB-2/EFN-1 are divergent members of their families,
vab-2/efn-1 mutations cause variable and incompletelywe asked whether they bind one another with high affin-
penetrant defects in epidermal morphogenesis (Tableity. Full-length VAB-2/EFN-1 was expressed as a cell
1; Figure 3). We analyzed the phenotypes caused by thesurface protein in 293T cells (Figure 2B). To determine
strong vab-2/efn-1 allele ju1 in detail. About 10% ofwhether VAB-2/EFN-1 was GPI-anchored, we incubated
vab-2/efn-1 mutants arrested during embryonic stages;VAB-2/EFN-1-expressing cells with phosphatidylinosi-
about 20% of vab-2/efn-1 animals arrested as larvaetol-specific phospholipase C (PI-PLC), an enzyme that
due to defects in head and tail morphogenesis. Aboutcleaves GPI anchors (Ferguson and Williams, 1988).
50% of vab-2/efn-1 adults displayed the ªNotched-VAB-2/EFN-1 was released into the supernatant by PI-
headº phenotype, resulting from aberrant morphogene-PLC treatment (Figures 2A and 2D), showing that VAB-2/
EFN-1 is GPI anchored. sis of head epidermis (Figure 3J). The expression of
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in epidermal enclosure (Figure 3B). Because most vab-2/
efn-1 mutants displayed phenotypes similar to those
of vab-1 mutants, we classified them using the same
criteria (George et al., 1998). Twelve percent of vab-2/
efn-1 embryos displayed severe defects in gastrulation
cleft closure and arrested in epidermal enclosure (class
I and II phenotypes; Figures 3G and 3H). Sixteen percent
of vab-2/efn-1 embryos displayed defects in gastrula-
tion cleft closure, underwent normal epidermal enclo-
sure, and elongated to the 2- or 3-fold stage, when they
ruptured in the head (Figure 3I); this phenotype is similar
to the vab-1 class IV phenotype. Most vab-2/efn-1 em-
bryos (72%) displayed mild defects in morphogenesis
(class V; Figure 3J).
The phenotypes of vab-2/efn-1 mutants were thus
largely indistinguishable from those of vab-1 mutants.
The major difference was that vab-1 null mutations
caused more penetrant defects than those of strong
vab-2/efn-1 mutants (see below). vab-2/efn-1 adults
were also more frequently egg-laying defective than
vab-1 mutants. Thus, vab-2/efn-1 mutant phenotypes
were mostly overlapping with those of vab-1 mutants,
consistent with vab-2/efn-1 and vab-1 functioning in the
same process.
VAB-2/EFN-1 Is Expressed in a Subset of Neurons
during Embryogenesis, Adjacent
to VAB-1-Expressing Neurons
To determine the cells in which VAB-2/EFN-1 was ex-
pressed, we made anti-VAB-2/EFN-1 antisera. These
antisera detected VAB-2/EFN-1 in animals that overex-Figure 1. vab-2 Encodes C. elegans Ephrin EFN-1
pressed VAB-2/EFN-1 from rescuing transgenes, but did(A) Genetic and physical maps of the vab-2/efn-1 locus and structure
not detect endogenous VAB-2/EFN-1, suggesting thatof the vab-2/efn-1 gene. vab-2/efn-1 maps 0.1 map units to the left
of osm-3 on LGIV. Cosmid, YAC, and fosmid clones were mapped VAB-2/EFN-1 may be expressed at low levels. We first
by the C. elegans genome project; vab-2/efn-1 is rescued by a 12 detected VAB-2/EFN-1 expression at the 100-cell stage
kb KpnI fragment (pCZ126) from fosmid H25K18, which overlaps in several cells in the anterior and posterior (data not
cosmid W07G9. vab-2/efn-1 is the predicted gene Y37E11A_93.a in
shown). After gastrulation VAB-2/EFN-1 was expressedthe C. elegans genomic database. The intron±exon structure of vab-2/
in lateral cells, corresponding to neuroblasts. Duringefn-1 is conserved with those of vertebrate ephrin-As: the locations of
epidermal enclosure VAB-2/EFN-1 was expressed inthe introns between exons 1, 2, and 3 are conserved between vab-2/
efn-1, murine ephrin-A3, ephrin-A4, and human ephrin-A2 (Cerretti neurons in the midanterior of the embryo, beneath the
and Nelson, 1998). leading cells of the epidermis (Figures 4A and 4B), and
(B) Sequence of VAB-2/EFN-1 protein, showing locations of muta- in several tail neurons. At later stages VAB-2/EFN-1 was
tions. The signal sequence (italicized) is predicted to be cleaved
expressed in the processes of many neurons (Figure 4C),after residue A22. The conserved putative receptor-binding domain
and in the pharynx. Thus, VAB-2/EFN-1 was expressed(residues 28±149) is followed by a spacer (residues 150 to 260). The
mostly in the developing nervous system and not inVAB-2/EFN-1 C terminus (italicized) is hydrophobic and is predicted
to be cleaved after S260. epidermal cells before or during epidermal enclosure.
(C) Alignment of the VAB-2/EFN-1 conserved domain with those of As cell contact is necessary for ephrins to signal to
the most similar ephrin-A and ephrin-Bs. Conserved domains were Eph receptors, we asked whether VAB-1 and VAB-2/
aligned using CLUSTAL W; identities to VAB-2/EFN-1 are in black.
EFN-1 were expressed in adjacent cells. We constructedWithin this domain, VAB-2/EFN-1 is 38% identical (47/121 residues)
strains in which both VAB-2/EFN-1 and GFP-taggedto human ephrin-B2 (Cerretti et al., 1995) and 28% identical (34/
VAB-1 were expressed from rescuing transgenes, and121) to chicken ephrin-A5 (Drescher et al., 1995). Asterisks mark
residues affected by vab-2/efn-1 missense mutations. detected these proteins by staining with anti-GFP and
anti-VAB-2 antibodies. During ventral enclosure, VAB-1
was expressed in head neurons anterior to the leading
cells of the epidermis, and in the ventral body of theseveral neuronal and epidermal marker genes was nor-
mal in vab-2/efn-1 mutants (data not shown), suggesting embryo (blue in Figures 4D±4F); VAB-2/EFN-1 (green)
was expressed in adjacent neurons. Thus, VAB-2/EFN-1that vab-2/efn-1 is not required for cell fate specification.
To understand the role of vab-2/efn-1 in morphogene- expressing cells contact VAB-1-expressing cells during
embryogenesis.sis, we used four-dimensional (4D) Nomarski micros-
copy (Thomas et al., 1996) to examine vab-2/efn-1 mu- We also asked whether mutations in the VAB-1 recep-
tor led to disorganization of VAB-2/EFN-1 expressingtant embryos. We found that vab-2/efn-1 mutants, like
vab-1 mutants, were defective in two phases of em- cells, as expected from the disorganization of neuro-
blasts following gastrulation in vab-1 or vab-2/efn-1 mu-bryogenesis: in the movements of neuroblasts during
closure of the ventral gastrulation cleft (Figure 3A), and tants. We found that in vab-1(e2) mutants the VAB-2/
Cell
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EFN-1 expressing cells were frequently more spread out
(Figures 4G and 4H; compare with 4A and 4B), sug-
gesting that VAB-1 signaling prevents spreading of VAB-
2-expressing cells. Spreading of VAB-2/EFN-1-express-
ing cells was seen in animals carrying vab-1 null or
extracellular domain alleles (e2027, e699; data not
shown). These data suggest that epidermal defects in
vab-1 or vab-2/efn-1 mutants may be due to disorgani-
zation of neurons.
VAB-2/EFN-1 Can Function in Neurons to Regulate
Epidermal Morphogenesis
The expression pattern of VAB-2/EFN-1 suggested that,
like VAB-1, it might function nonautonomously in the
developing nervous system for epidermal development.
We first tried to address this using genetic mosaic analy-
sis and found that vab-2/efn-1 was required in several
lineages that generate both epidermis and neurons (data
not shown). However, late losses of vab-2/efn-1 function
in neural precursors did not cause Vab phenotypes,
probably because the Vab-2 phenotype is weak. We
therefore asked whether neuronal expression of VAB-2/
EFN-1 was sufficient to suppress the epidermal defects
of vab-2/efn-1 mutants. The unc-119 gene is expressed
in all neuronal precursors and neurons (Maduro and
Pilgrim, 1995). We generated animals in which VAB-2/
EFN-1 was expressed under the control of the unc-119
promoter, and found that this panneural expression of
VAB-2/EFN-1 was able to partially suppress epidermal
morphology and lethal defects of vab-2/efn-1 mutants
(Figures 5A and 5B, black bars). The partial rescue may
be because panneural expression of VAB-2/EFN-1 did
processing. Smaller products specific to VAB-2/EFN-1 transfected
cells may be breakdown products. A single product (arrow) was
detected in supernatants after treatment with PI-PLC (lane 5).
(B) Confocal image of 293T cells expressing VAB-2/EFN-1, detected
with anti-VAB-2/EFN-1 antisera, showing localization to the cell sur-
face. Bar, 20 mm (B±D).
(C) 293T cells expressing the C90Y (e141) mutated form of VAB-2/
EFN-1, visualized as in (B), showing equivalent expression levels;
similar results were obtained for the P108L (e1208) mutant (not
shown).
(D) Anti-VAB-2/EFN-1 staining was abolished when cells expressing
wild-type VAB-2/EFN-1 were pretreated with PI-PLC to cleave GPI
anchors.
(E±G) VAB-1-AP specifically binds to VAB-2/EFN-1 expressing cells.
Untransfected 293T cells (E) or cells transfected with VAB-2/EFN-1
(F) were incubated with 25 nM VAB-1-AP and the binding visualized
using AP enzymatic activity; the interaction is sensitive to pretreat-
ment with PI-PLC (G), or with anti-VAB-2 antisera (not shown). Bar 5
150 mm.
(H±J) Colocalization of VAB-1-AP and VAB-2/EFN-1. Cells express-
ing VAB-2/EFN-1 were treated with VAB-1-AP, and stained with anti-
AP (red) and anti-VAB-2 antibodies (green). The merged image (J)
shows colocalization (yellow). Bar 5 10 mm.
Figure 2. VAB-2/EFN-1 Is GPI-Anchored and Binds VAB-1 with High (K) Equilibrium binding of VAB-1-AP to VAB-2/EFN-1-transfected
Affinity 293T cells (open squares) or untransfected (filled squares). Specific
binding is also shown as a Scatchard plot (right). Error bars in (K)(A) Western blot of lysates of 293T cells transiently transfected with
full-length VAB-2/EFN-1, probed with anti-VAB-2/EFN-1 antisera. A and (L) indicate standard deviations (n 5 3).
(L) Mutations in the VAB-2/EFN-1 conserved domain abolish VAB-30 kDa product (arrowhead) was specific to transfected cells (lane
2), was not seen in the cell supernatant (lane 4), and likely corre- 1-AP binding. Binding was measured at 25 nM VAB-1-AP, using
cells expressing wild-type VAB-2/EFN-1 or the C90Y and P108Lsponds to VAB-2/EFN-1. The predicted molecular weight of the
mature VAB-2/EFN-1 peptide is 26 kDa; the difference in apparent mutants. UT 5 untransfected. AP 5 secreted alkaline phosphatase
binding to 293T cells expressing wild-type VAB-2/EFN-1.molecular weight may reflect addition of the GPI anchor and other
Ephrin Signaling in C. elegans Morphogenesis
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Figure 3. vab-2/efn-1 Mutants Are Defective in Gastrulation Cleft Closure and Epidermal Enclosure
(A) Schematic of gastrulation cleft closure, ventral view.
(B) Schematic of epidermal enclosure, ventral view.
(C±F) Morphogenesis of wild-type embryos. (C) Between 230 and 290 min postfertilization, the ventral cleft following gastrulation closes. (D)
Between 310 and 360 min postfertilization, the epidermis encloses ventrally. (E) Wild-type 2-fold embryo, lateral view, dorsal up. (F) Wild-type
first larval stage (L1). Bar, 10 mm (C±E and G±I), 20 mm (F and J). Anterior is to the left in all panels; ventral views (C, D, G, and H) or lateral
views (E, F, I, and J).
(G±J) Morphogenesis of vab-2/efn-1(ju1) embryos. (G) Gastrulation cleft of class I vab-2/efn-1(ju1) embryo. 8% (4/50) of vab-2/efn-1 embryos
displayed a class I phenotype (cf. 14% of vab-1 embryos). Two early gastrulation clefts formed a single deep cleft (arrow) that persisted until
epidermal enclosure (H); epidermal cells failed to migrate past the equator of the embryo. 4% (2/50) of animals displayed a class II phenotype,
which is similar to class I but slightly weaker. (I) Rupture of head epidermis in vab-2/efn-1(ju1) class IV embryo, 1.5-fold stage. 16% (8/50) of
vab-2 embryos displayed a class IV phenotype, in which the gastrulation cleft was larger than normal yet closed up properly; embryos
underwent epidermal enclosure and elongated to 2-fold or 3-fold stages, then ruptured in the head region (arrow). (J) Abnormal morphogenesis
of head and tail epidermis in a class V vab-2/efn-1(ju1) L1 animal; 66% (33/50) of animals displayed a class V phenotype, in which cleft closure
was normal and the epidermis closed fully. In some class V embryos the epidermis was malformed, leading to the Notch head phenotype in
larvae; in 6% (3/50) of embryos the cleft was deeper than normal, and the embryo developed to hatching.
not exactly mimic the wild-type VAB-2/EFN-1 expres- thus vab-2/efn-1 mutations should not show interac-
tions with vab-1(k) mutations. Surprisingly, vab-2/efn-1;sion pattern. In contrast, epidermal expression of VAB-2/
EFN-1 did not significantly rescue Vab-2 phenotypes vab-1(k) double mutants showed a dramatic enhance-
ment of Vab-1 phenotypes, and resembled vab-1(0)(Figures 5A and 5B). These data suggest that VAB-2/
EFN-1 can function nonautonomously in neurons to con- strains in phenotype and penetrance (Figure 6B). Thus,
vab-2/efn-1 mutations synergized strongly with vab-1(k)trol epidermal development.
mutations, although not with vab-1(0) mutations, sug-
gesting that vab-2/efn-1 does not solely act in the vab-1vab-2/efn-1 Mutations Synergize with vab-1
(Kinase) Mutations kinase-dependent pathway.
We therefore asked if vab-2/efn-1 functions in a path-To address whether VAB-2/EFN-1 acts as a ligand for
VAB-1 in vivo, we used double mutant analysis to ask way affected by mutations in the VAB-1 extracellular
domain. The vab-1 mutation e699 encodes a missenseif vab-1 and vab-2/efn-1 affect a single pathway. If vab-2/
efn-1 and vab-1 mutations affect a single pathway, alteration in the ligand-binding domain of VAB-1 (Hima-
nen et al., 1998). We found that vab-1(e699) did notthen the phenotype of a vab-1 null mutant [vab-1(0)]
should not be enhanced by a vab-2/efn-1 null mutation synergize strongly with vab-2/efn-1(0) mutations (Figure
6B). While the e699 mutation alone causes a stronger[vab-2/efn-1(0)]. We found that the phenotypes of nine
vab-1(0); vab-2/efn-1(0) strains resembled those of vab- phenotype than vab-1(k) alleles, the vab-1(e699); vab-2/
efn-1(0) double mutants were significantly weaker than1(0) strains (Figure 6A). The embryonic phenotypes of
the double mutants were indistinguishable from those vab-1(k); vab-2/efn-1(0) double mutants. Thus, vab-2/
efn-1(0) mutations specifically synergized with kinaseof vab-1(0) mutants, as judged by 4D analysis (data not
shown). Although most double mutant strains showed domain alleles of vab-1 and not with a more severe
extracellular domain mutation. vab-2/efn-1 might there-a slight increase in lethality, this was significant in only
four of nine strains (Figure 6A). These data suggest that fore act in a kinase-independent pathway that is also
affected by the vab-1(e699) mutation.vab-2/efn-1 functions mainly in the same pathway as vab-1.
Mutations that disrupt the kinase domain of VAB-1
[vab-1(k)] do not eliminate vab-1 function, suggesting Discussion
that VAB-1 has both kinase-dependent and kinase-inde-
pendent functions (George et al., 1998). As VAB-2/EFN-1 We previously reported that vab-1 encodes a C. elegans
Eph receptor tyrosine kinase that is required in neuronsis a GPI-anchored ephrin, we predicted that it would
mediate the kinase-dependent function of VAB-1, and for normal neural and epidermal morphogenesis. Here
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Figure 4. VAB-2/EFN-1 Is Expressed in Neu-
rons Adjacent to VAB-1-Expressing Cells
Confocal images of VAB-2/EFN-1 expression
from the juIs53 [vab-2/efn-1(1)] transgene,
visualized using anti-VAB-2/EFN-1 antibod-
ies (green); epidermal adherens junctions
were visualized using the MH27 monoclonal
antibody (red); VAB-1::GFP expression in
(D)±(F) visualized with anti-GFP antibodies
(blue). Bar, 10 mm (A, B, D±H), 20 mm (C).
(A and B) Ventrolateral and ventral views of
early enclosure. During epidermal enclosure
VAB-2/EFN-1 is expressed in many neurons
in the anterior and in several in the tail. Based
on double staining with the epidermal mark-
ers MH27 and LIN-26, VAB-2/EFN-1 is not
expressed in epidermal cells or precursors.
Leading epidermal cells (arrows) appear to
migrate directly over VAB-2/EFN-1-express-
ing neurons.
(C) Late embryo, 3-fold stage; the nerve ring
(arrowed), head neurons, and dorsal and
ventral nerve cords express VAB-2/EFN-1.
Strong expression is also seen in the meta-
corpus, isthmus, and valve regions of the
pharynx.
(D) Triple label immunofluorescence (confo-
cal section) showing VAB-2/EFN-1 (green),
VAB-1::GFP (blue), and MH27 (red). Lateral
view during early enclosure; leading edges of
epidermal cells are arrowed.
(E and F) VAB-2/EFN-1 and VAB-1::GFP ex-
pression after leading cells have met at the
ventral midline (arrow). Ventral views; (E) is a
confocal section showing only VAB-2/EFN-1
and VAB-1::GFP channels; (F) is a confocal
projection of the ventral half of the embryo in
all three channels. VAB-1::GFP and VAB-2/
EFN-1 expressing cells form distinct, adja-
cent populations.
(G and H) VAB-2/EFN-1 expression in vab-1(e2)
mutant embryos. VAB-2/EFN-1-expressing
cells become more spread out, compare
brackets showing extent of VAB-2/EFN-1
staining in (A) and (B) versus (G) and (H).
Spreading of VAB-2/EFN-1-expressing cells
was seen in 70% (135/192) of vab-1(e2) em-
bryos. Mild spreading was seen in 33% (12/
36) of control juIs53 embryos.
we show that VAB-2/EFN-1 is a GPI-anchored ephrin are likely to be conserved amongst all metazoans. Verte-
brate ephrins are GPI anchored (ephrin-As) or trans-ligand for VAB-1, and that VAB-2/EFN-1 is predomi-
membrane (ephrin-Bs) proteins. VAB-2/EFN-1 is GPI an-nantly expressed in neurons. The epidermal defects in
chored and thus structurally like vertebrate ephrin-As.vab-2/efn-1 mutants can be suppressed by neuronal
However, the conserved domain of VAB-2/EFN-1 resem-but not epidermal expression of VAB-2/EFN-1. Our data
bles those of vertebrate ephrin-Bs in sequence. Thus,support a model in which signaling between neurons
VAB-2/EFN-1 is an unusual ephrin and might resembleis required nonautonomously for C. elegans epidermal
a common ancestor of the two vertebrate subclasses.development.
Other C. elegans ephrins (Wang et al., 1999), like VAB-2/
EFN-1, are predicted to be GPI anchored with conserved
VAB-2/EFN-1 is a C. elegans Ephrin Similar to Both domains more similar to those of ephrin-Bs. The C. ele-
GPI-Linked and Transmembrane Ephrins gans genome sequence encodes one Eph receptor,
VAB-2/EFN-1 is a member of the ephrin family of ligands VAB-1, suggesting that all four worm ephrins might inter-
for Eph receptors. Ligands for Eph receptors were iden- act with the VAB-1 receptor.
tified by expression cloning (Bartley et al., 1994; Cheng
and Flanagan, 1994; Davis et al., 1994), and in assays VAB-2/EFN-1 May Partly Function in a VAB-1
for proteins involved in axon guidance (Drescher et al., Kinase-Independent Pathway
1995). Ephrins have previously been reported in verte- Mutations that disrupt the kinase domain of VAB-1
cause weak mutant phenotypes, suggesting that VAB-1brates; our data show that, like their receptors, ephrins
Ephrin Signaling in C. elegans Morphogenesis
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Figure 5. Neuronal VAB-2/EFN-1 Can Suppress Epidermal Defects Figure 6. Double Mutant Analysis of vab-1 and vab-2/efn-1
of vab-2/efn-1 Mutants (A) Analysis of strains doubly mutant for vab-1 null mutations (dx14,
Extrachromosomal arrays expressing VAB-2/EFN-1 in neurons dx31, or e2027) and for vab-2/efn-1 null mutations (e96, ju1, or
(Punc-119::VAB-2/EFN-1), epidermal cells (Ppax-3::VAB-2/EFN-1), n1443). Error bars indicate standard deviations. Double mutant
or all epithelial cells (Pjam-1::VAB-2/EFN-1) were crossed into vab-2/ strains marked * were significantly more penetrant (p 5 0.05) than
efn-1(ju1) backgrounds. At least three broods were scored for each the corresponding vab-1 single mutant.
genotype; adult roller animals were scored for the Vab epidermal (B) Analysis of strains doubly mutant for vab-1 kinase domain muta-
phenotype. Error bars indicate standard deviations (n $ 3). Asterisks tions (e2, e116, or e118), the vab-1 extracellular domain allele e699,
indicate significant differences (Student's t test, p 5 0.05) from and vab-2/efn-1 null mutations.
negative control lines bearing the pRF4 array (juEx219) alone. The
rescuing vab-2/efn-1 array juEx127 is included as a positive control.
data suggest that some or all of VAB-2/EFN-1's func-(A) Percentage of adult rollers in vab-2/efn-1(ju1) backgrounds that
tions may be in a VAB-1 kinase-independent pathway.displayed the Vab epidermal phenotype. The Punc-119::VAB-2/
There are several possible ways in which GPI-linkedEFN-1 arrays displayed significant rescue; the Ppax-3::VAB-2/EFN-1
and Pjam-1::VAB-2/EFN-1 arrays did not show rescuing activity. ephrins such as VAB-2/EFN-1 could function in kinase-
(B) Percentage lethality in vab-2/efn-1(ju1) transgenic lines. Lethality independent pathways. First, VAB-1 and VAB-2/EFN-1
was reduced in both Punc-119::VAB-2/EFN-1 lines; the reduction might act as cell adhesion molecules, independent of
was significant in only one line. signaling activity. Second, analogous to the signaling
functions of transmembrane ephrins, VAB-2/EFN-1
could mediate a ªreverseº signal, via mechanisms
has both kinase-dependent and kinase-independent known for other GPI-linked proteins: VAB-2/EFN-1 might
functions. As VAB-2/EFN-1 is a GPI-linked ephrin, we associate with transmembrane coreceptors, as shown
expected that VAB-2/EFN-1 would only function to acti- for the CNTF receptor (Davis et al., 1991), or it could
vate the VAB-1 kinase, and thus genetically should be in localize to membrane rafts, allowing a signal to be trans-
the same pathway as vab-1 kinase mutations. Strikingly, duced to the VAB-2/EFN-1-expressing cell (Simons and
vab-2/efn-1 mutations synergized strongly with vab-1(k) Ikonen, 1997; Thomas and Brugge, 1997). Recent work
mutations. Mutations that show synergistic enhance- suggests that EphA receptors have nonautonomous ef-
ment may affect redundant pathways (Guarente, 1993). fects, suggesting that vertebrate ephrin-As might also
vab-2/efn-1 mutations did not synergize with a vab-1 transduce reverse signals (Araujo et al., 1998). Finally,
extracellular domain mutation, showing that the syner- the kinase-independent function of VAB-1 need not in-
volve reverse signaling: ligands could signal via thegism is specific to kinase domain alleles of VAB-1. These
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Experimental ProceduresVAB-1 cytoplasmic domain in a way that does not in-
volve VAB-1 kinase activity. Ephrins can activate Eph
Genetic Analysisreceptors in multiple ways that do not correlate with
C. elegans worms were cultured as described by Brenner (1974) at
receptor phosphorylation (Stein et al., 1998), although 208C unless noted. Mutations used were: LGII: vab-1(e2, e116, e118,
all known intracellular responses of Eph receptors re- dx14, dx31, e2027); LGIV: unc-17(e113), dpy-13(e184sd); LGX: lin-
15(n765ts). Mutations are described in George et al. (1998) or Hodg-quire an active kinase. Further study of the VAB-2/EFN-1
kin (1997). vab-2/efn-1 alleles were isolated by S. Brenner (e96,pathway may distinguish these possibilities.
e141), J. Hodgkin (e1208), S. Ahmed (e2640), Y. Jin (ju1), M. Ding
(ju90), L. Bloom (n1443), H. Chamberlin (sy167), and I. Katsura (ut78).
All vab-2/efn-1 alleles were induced after ethylmethanesulfonate
Signaling within the Developing Nervous System Is mutagenesis. The strong vab-2/efn-1 alleles e96, n1443, and ju1
Required for C. elegans Epidermal Morphogenesis behave as recessive zygotic mutations (data not shown). Map data
are available from the Caenorhabditis Genetics Center. PenetranceThe VAB-1 Eph receptor is required in neurons for epi-
of Vab-2 mutant phenotypes was quantitated as described (Georgedermal morphogenesis. How might lack of VAB-1 in neu-
et al., 1998). Three to seven broods were scored for each genotyperons cause defects in the epidermis? We proposed two
in Table 1 and Figure 6.models for this nonautonomy of VAB-1 (George et al.,
vab-1; vab-2 double mutants were constructed using dpy-
1998): the ªsteric hindranceº model and the ªreverse 13(e184sd) as a dominant marker in trans to vab-2. vab-2/unc-17
signalingº model; these models are not mutually exclu- dpy-13 heterozygous males were mated with vab-1; unc-17 dpy-13
hermaphrodites, and semi-Dpy (vab-1/1; unc-17 dpy-13/vab-2) F1sive. In the steric hindrance model, VAB-1 signaling op-
cross progeny were picked. Vab semi-Dpy F2 animals were picked,erates between neuroblasts and neurons, and lack of
and Vab non-Dpy F3 animals were picked from their progeny, ofVAB-1 causes neurons to be disorganized; enclosure is
putative genotype vab-1; vab-2. Homozygosity for both mutationsdefective because the epidermal cells cannot move over
was confirmed by complementation tests. We analyzed differences
the abnormal neuronal substrate. In the reverse signal in lethality using one-way Anova (Statview). Significance was evalu-
model, VAB-1 signals directly from neurons to the epi- ated using the Fisher PLSD post hoc test with a significance level
of p 5 0.05.dermal cells; in vab-1 mutants such cues are absent
and epidermal cells fail to migrate normally.
Four-Dimensional MicroscopyOur analysis of vab-2/efn-1 supports a steric hin-
We made 4D movies using a Zeiss Axioskop with Z axis drive anddrance model for the nonautonomous role of ephrin
shutter (Ludl Electronic Products). Images were collected with asignaling. VAB-2/EFN-1 is mostly expressed in neuro-
Dage-MTI VE1000 CCD camera, digitized with a Scion AG-5 frame
blasts or neurons, and neuron-specific expression of grabber, converted to Quicktime movies and played using 4-D Grab-
VAB-2/EFN-1 can partly rescue epidermal defects of ber and 4-D Viewer software (C. Thomas, University of Wisconsin,
vab-2/efn-1 mutants, showing that VAB-2/EFN-1 can Madison). To make movies we recorded 30 focal planes 0.5 mm
apart, every 60 s from early gastrulation (z100 min postfertilization)function in neurons to regulate epidermal development.
until the embryo had reached a terminal phenotype. We recordedFurthermore, mutations in the VAB-1 receptor cause
movies from 50 vab-2(ju1) embryos. Fourteen of these 50 embryosdisorganization of the VAB-2/EFN-1-expressing neu-
arrested in embryogenesis; the difference in penetrance from that
rons. The spreading of VAB-2/EFN-1-expressing cells observed in brood counts probably reflects the small sample size,
in vab-1 mutants likely reflects abnormal cell migration as 100% of control embryos hatched under our conditions.
or adhesion, as vab-1 mutants do not display cell fate
transformations. This role of VAB-1 in preventing cell Cloning and Molecular Analysis of vab-2/efn-1
We identified an ephrin gene in sequence of the YAC clone Y37E11.spreading is strikingly reminiscent of the cell sorting
A genomic fosmid clone, H25K18, that contains the vab-2/efn-1functions of Eph signaling in vertebrate neurogenesis
gene was identified by Stephanie Chissoe (C. elegans Genome Con-(Mellitzer et al., 1999; Xu et al., 1999).
sortium). We subcloned a 12.8 kb KpnI fragment of H25K18 into
We conclude that VAB-2/EFN-1 signaling to VAB-1 pBluescript to create the clone pCZ126 (Figure 1). vab-2/efn-1(e96)
occurs between neuronal precursors, and regulates cell hermaphrodites were transformed with pCZ126 (30 mg/ml) and pRF4
adhesion or movement. In the absence of VAB-1 or (30 mg/ml), which confers a roller phenotype, using standard meth-
ods (Mello et al., 1991). Transgenic lines were established fromVAB-2/EFN-1, neuroblasts fail to close up the ventral
transformed F2 animals. 3/3 lines (arrays juEx127, juEx128, juEx129)gastrulation cleft and as a result, descendant neurons
showed rescue of adult Vab phenotypes (2.2% of Rols were Vab,are disorganized. Disorganized neurons might block epi-
n 5 498) compared to control lines bearing pRF4 alone (66.1% of
dermal movements directly (true ªsteric hindranceº) or Rols were Vab, n 5 168). An integrated version of juEx127, juIs53,
indirectly: for example, the boundary between VAB-1 was isolated after X-ray mutagenesis, and rescued the lethality of
and VAB-2/EFN-1-expressing cells might attract migrat- vab-2/efn-1(e96) (1.6% lethality, n 5 303; 0.5% Vab, n 5 727).
We used RT-PCR to generate cDNAs containing the predicteding epidermal cells; if this boundary is disorganized,
vab-2/efn-1 open reading frame; the resulting clone (pCZ36) wasepidermal migrations would be disrupted. An analogous
sequenced. We found no evidence for alternative processing of thesituation might occur in vertebrate angiogenesis, where
vab-2/efn-1 message from RT-PCR experiments. The vab-2/efn-1
ephrin signaling between endocardial cells is required cDNA sequence contains an 837 bp open reading frame, and a 39
for the development of overlying myocardial trabeculae UTR of z170 bp. We detected a vab-2/efn-1 transcript of z1.2 kb
(Wang et al., 1998). Such models do not rule out signaling using Northern blots of total C. elegans RNA (data not shown),
consistent with our cDNA analysis. We determined the sequencesfrom neurons to epidermis, possibly via other ephrins;
of vab-2/efn-1 mutant genomic DNAs as described (George et al.,however, of the three other C. elegans ephrins, at least
1998).two are expressed mainly in neurons (Wang et al., 1999,
and our unpublished data). The small number of Eph
Neuronal- and Epidermal-Specific VAB-2/EFN-1 Constructs
receptors and ephrins in C. elegans suggests that it will We amplified the vab-2/efn-1 coding sequence using PCR and
be feasible to dissect the complete network of Eph/ cloned it into the unc-119 promoter vector pBY103 (Maduro and
Pilgrim, 1995) using the BamHI and MscI sites. Epidermal specificephrin signaling in a simple animal.
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vab-2/efn-1 constructs were made by replacing the unc-119 pro- 65% acetone, 8% formalin in 20 mM HEPES pH 7.0, for 20 min at
2208C. Cells were washed 3 times with HBAH buffer (Hank's bal-moter with a pax-3 (F27E5.2) promoter or a jam-1 promoter. The
pax-3 promoter is contained in the 3.2 kb BamHI-EcoRV fragment anced salt solution, 0.5 mg/ml BSA, 0.1% NaN3, 20 mM HEPES, pH
7.0. FITC-conjugated goat anti-rabbit antisera (Cappel) were usedof cosmid F27E5, and is expressed in embryonic epidermal cells
(A. D. C., unpublished results). jam-1 encodes the MH27 antigen, at 1:500 dilution in buffer A (Finney and Ruvkun, 1990), and incubated
at room temperature for 1 hr. Cells were washed in 63 1 ml bufferexpressed in all epithelial cells but not in neurons (Mohler et al.,
1998). Details of plasmid constructions are available on request. B and stored in 70% glycerol and 10% DABCO (1,4-diazobicylo-
[2.2.2]-octane) (Aldrich). To show colocalization of VAB-1-AP bind-Transgenic lines bearing the above constructs injected at high
concentrations (.30 ng/ml) frequently displayed lethality and mor- ing and VAB-2/EFN-1, VAB-1-AP (900 ng/ml) was bound to VAB-2/
EFN-1 expressing cells in complete medium for 1 hr at 378C. Cellsphogenetic defects. For rescue tests we reduced the concentration
of the constructs to levels that caused ,5% abnormal phenotypes were washed and fixed as above. VAB-1-AP was detected by anti-
AP monoclonals (Genzyme) at 1:1000 dilution, and VAB-2/EFN-1in a vab-2/efn-1(1) background, with the exception of the Ppax-
3::VAB-2/EFN-1 arrays, which cause 15%±20% Vab phenotypes in detected by anti-VAB-2/EFN-1 antisera (1:500). Primary antibodies
were incubated for 2 hr to overnight at room temperature, and stain-adults. Punc-119::VAB-2/EFN-1 was injected at 15 ng/ml (arrays
juEx213, juEx214); Ppax-3::VAB-2/EFN-1 was injected at 30 ng/ml ing visualized using appropriate secondary antibodies.
For the Western blot analysis of VAB-2/EFN-1, cells from a 25(arrays juEx215, juEx216); Pjam-1::VAB-2/EFN-1 was injected at 10
ng/ml (arrays juEx217, juEx218). All constructs were injected with cm2 flask of confluent cells were washed off, spun (150 ml pellets)
and resuspended in 1 ml 23 sample buffer, boiled, and 20 ml loadedpRF4 at 30 ng/ml. Transgenic arrays transmitting to 30%±40% of
progeny were crossed into a vab-2/efn-1(ju1) background and res- onto a 15% acrylamide gel, subjected to SDS-PAGE, and elec-
troblotted onto nitrocellulose. Anti-VAB-2/EFN-1 was used at 1:1000cue of Vab-2 phenotypes scored in blind tests.
dilution. Anti-rabbit HRP-conjugated antibodies (Amersham) were
used at 1:5000 dilution and detected using Super Signal (Pierce).VAB-2/EFN-1 Antibody Production and
C. elegans Immunocytochemistry To generate mutant forms of VAB-2/EFN-1 in pcDNA1, we de-
signed primers containing the missense mutations in e141 andTo express VAB-2/EFN-1 in bacteria we cloned residues 27 to 240
of VAB-2/EFN-1 into pGEX4T3 (Pharmacia). GST-VAB-2 fusion pro- e1208 and used these primers in PCRs. First, two PCRs were carried
out using vab-2/efn-1 cDNA as template: one, using a 59 senseteins were induced in E. coli TG1 cells, purified by SDS-PAGE, and
injected into rabbits. Anti-GST-VAB-2 antisera were preabsorbed primer specific for vab-2/efn-1 and the antisense primer of the com-
plementary mutated primer; and two, using the sense primer of theby incubation with protein acetone powders derived from 293T cells,
complementary mutated primer and a 39 anti-sense primer specificE. coli, and vab-2(ju1) worms, and by binding to a GST-VAB-2/
for vab-2/efn-1. The two PCR products were pooled and used asEFN-1 Affigel-15 (BioRad) column, followed by extensive washing
templates in a third PCR using the original 59 and 39 vab-2/efn-1and elution.
primers to generate a vab-2/efn-1 cDNA containing the desired mu-To stain C. elegans embryos, we fixed the embryos in methanol
tation. Clones were confirmed by sequencing.and 2% paraformaldehyde and permeabilized them by freeze-thaw-
ing (Finney and Ruvkun, 1990). Data were collected from strain
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